Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion type Assertion NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_head.
- NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion description "[To determine the cancer-associated functional implications of PADs, we designed a small molecule PAD inhibitor (called Chor-amidine or Cl-amidine), and tested the impact of this drug on the cell cycle.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_provenance.
- NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion evidence source_evidence_literature NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_provenance.
- NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion SIO_000772 23308284 NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_provenance.
- NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion wasDerivedFrom befree-20150227 NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_provenance.
- NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_assertion wasGeneratedBy ECO_0000203 NP944959.RAU0M-dEO1ZOWozfNV_NwLoRxi9r9xovEDMhJI_SwLKkM130_provenance.